Community Outreach and Engagement

社区外展和参与：项目摘要 Siteman癌症中心（SCC）的集水区横跨密苏里州和伊利诺伊州的82个县。的 各州的健康覆盖率和总体癌症负担水平差异很大。的人口 流域是非常多样化的，15%的人口生活在农村地区，29%的人口生活在医疗保健领域。 欠发达地区（MUA）。流域内少数民族人口占总人口的20.5%。 然而，非裔美国人中居住在MUA的SCC患者比例显著较高（31.3%）， 与白色患者（25.2%）相比。我们的集水区作为一个整体携带着不成比例的高癌症 癌症负担加重，晚期诊断发生率增加，癌症死亡率高。事实上， 在乳腺癌、肺癌、前列腺癌和结直肠癌方面，SCC流域县的百分比处于美国最高的四分位数之内 癌症死亡率为了解决我们流域的差异和癌症负担，SCC调查人员已经 开发量身定制的教育材料，癌症特定的社区合作伙伴关系，临床试验参与 监测系统，并扩大临床服务的一部分，SCC的全面推广战略。SCC的 社区外展和参与（COE）组件建立在此基础上，目标是维持 合作伙伴关系，并确保所有癌症患者和社区都能从临床和科学研究中受益。 预付款。SCC的特遣队所属装备部分处理和监测服务不足人口之间的差距， 特别是种族（少数民族）、地理（农村）、获得服务的机会（医疗服务不足的地区）及其 互动SCC的COE组成部分被组织成内部咨询委员会（IAB）、社区咨询委员会（Community Advisory Board）、社区咨询委员会（Community Advisory Board）和社区咨询委员会（Community Advisory Board）。 委员会（CAB）;临床研究外展（CSO）团队;和六个半全职等效工作人员。这些 小组共同努力实现COE的目标：（1）监测和评估癌症负担及相关的 （2）加快实施外展、教育和临床 与社区合作，减少SCC中的癌症负担和相关差异 （3）支持研究，以减少SCC集水区的癌症负担和相关差异 通过：（3a）支持基于社区的健康差距研究，（3b）持续评估和 教育以促进临床试验参与的多样性。为了实现这些目标，COE将在现有的 强有力的社区和区域合作伙伴关系，这源于SCC作为供应商的关键角色， 研究中心在我们的集水区。通过实现上述目标，SCC将确保该中心是最好的 解决癌症在我们流域的影响，并正在发展一个坚实的基础设施，以维持积极的 影响和加强SCC研究向临床实践的转化。这些目标共同努力， 癌症负担和SCC流域的相关差异。

COMMUNITY OUTREACH AND ENGAGEMENT: PROJECT SUMMARY The catchment area of Siteman Cancer Center (SCC) spans 82 counties across Missouri and Illinois. The counties exhibit significantly different levels of health coverage and overall cancer burden. The population of the catchment is extremely diverse, with 15% of the population living in a rural area, and 29% in a Medically Underserved Area (MUA). Minority populations in the catchment make up 20.5% of the total population. However, a significantly higher proportion of SCC patients who are African-American live in a MUA (31.3%), compared to White patients (25.2%). Our catchment area as a whole carries a disproportionately high cancer burden, with increased incidence of late stage diagnoses and a high cancer mortality. In fact, a significant percentage of SCC catchment counties fall within the highest US quartile for breast, lung, prostate, and colorectal cancer mortality. To address the disparities and cancer burden in our catchment, SCC investigators have developed tailored educational materials, cancer-specific community partnerships, a clinical trial participation monitoring system, and expanded clinical services as part of SCC’s Comprehensive Outreach Strategy. SCC’s Community Outreach and Engagement (COE) component builds on this foundation with the goal to sustain partnerships and assure that all cancer patients and communities can benefit from clinical and scientific advances. SCC’s COE component addresses and monitors disparities among underserved populations, specifically racial (minority), geography (rural), access to services (medically underserved areas), and their interaction. SCC’s COE component is organized into an Internal Advisory Board (IAB); a Community Advisory Board (CAB); a Clinical Studies Outreach (CSO) team; and six and one-half full-time equivalents staff. These groups work together to accomplish the COE aims: (1) Monitor and evaluate the cancer burden and related disparities in the SCC catchment; (2) Accelerate the implementation of outreach, education, and clinical resources in collaboration with communities to reduce the cancer burden and related disparities in the SCC catchment; and (3) Support research to reduce the cancer burden and related disparities in the SCC catchment through: (3a) Support for community-based and health disparities research, and (3b) Continuous evaluation and education to promote diversity in clinical trial participation. To achieve these aims, COE will build upon existing strong community and regional partnerships that have emanated from SCC’s critical role as a provider and research center in our catchment area. By achieving the above aims, SCC will ensure that the center is best addressing the impact of cancer in our catchment and is developing a solid infrastructure for sustaining positive impacts and strengthening translation of SCC research to clinical practice. Together, these aims work to reduce the cancer burden and related disparities in SCC’s catchment.